| ABXAbacus Global Management, Inc. |
$235.2M |
15.5% |
2025 |
| ABXXFAbaxx Technologies Inc. |
n/a |
n/a |
n/a |
| ABBVAbbVie Inc. |
$61.2B |
6.9% |
2025 |
| ABTSAbits Group Inc |
$9.1M |
-31.4% |
2025 |
| ABVXAbivax S.A. |
n/a |
n/a |
2025 |
| ABLVAble View Global Inc. |
$105.2M |
0.8% |
2025 |
| AACOAbony Acquisition Corp. I |
n/a |
n/a |
n/a |
| ABVEFAbove Food Ingredients Inc. |
n/a |
n/a |
n/a |
| ABPOAbpro Holdings, Inc. |
n/a |
n/a |
2025 |
| ABSIAbsci Corp |
$2.8M |
-4,113.7% |
2025 |
| ASOAcademy Sports & Outdoors, Inc. |
$6.1B |
6.2% |
2025 |
| ACHCAcadia Healthcare Company, Inc. |
$3.3B |
-33.3% |
2025 |
| AAMIAcadian Asset Management Inc. |
$563.7M |
14.2% |
2025 |
| ACELAccel Entertainment, Inc. |
$1.3B |
3.9% |
2025 |
| ARXAccelerant Holdings |
$912.9M |
-156.1% |
2025 |
| ACNAccenture plc |
$74.2B |
11.3% |
2026 |
| ACCLAcco Group Holdings Ltd |
$4.9M |
20.9% |
2025 |
| ASIIAccredited Solutions, Inc. |
$688.9K |
-216.1% |
2023 |
| ACUTAccustem Sciences Inc. |
n/a |
n/a |
2025 |
| ACONAclarion, Inc. |
$75.7K |
-9,551.9% |
2025 |
| ACRSAclaris Therapeutics, Inc. |
$7.8M |
-829.6% |
2025 |
| ACRVAcrivon Therapeutics, Inc. |
n/a |
n/a |
2025 |
| ATNMActinium Pharmaceuticals, Inc. |
$90K |
-37,652.2% |
2025 |
| AEAQActivate Energy Acquisition Corp. |
n/a |
n/a |
n/a |
| ABOSAcumen Pharmaceuticals, Inc. |
n/a |
n/a |
2025 |
| ACXPAcurx Pharmaceuticals, Inc. |
n/a |
n/a |
2025 |
| GOLFAcushnet Holdings Corp. |
$2.6B |
7.4% |
2025 |
| ADAGAdagene Inc. |
$7.7M |
-229.6% |
2025 |
| ADGMAdagio Medical Holdings, Inc. |
$0 |
n/a |
2025 |
| AHCOAdaptHealth Corp. |
$3.2B |
-2.2% |
2025 |
| ADTIAdapti, Inc. |
n/a |
n/a |
n/a |
| ADAPYAdaptimmune Therapeutics PLC |
$178M |
-39.8% |
2024 |
| ADPTAdaptive Biotechnologies Corp |
$277M |
-21.5% |
2025 |
| ADOOYAdaro Energy PT |
n/a |
n/a |
n/a |
| XTXXFAdastra Holdings Ltd. |
CA$13.3M |
-32.2% |
2022 |
| ADXNAddex Therapeutics Ltd. |
CHF 404.1K |
1,746.0% |
2024 |
| ADDTFAddtech AB |
n/a |
n/a |
n/a |
| ADUSAddus HomeCare Corp |
$1.4B |
6.7% |
2025 |
| AGROAdecoagro S.A. |
$1.5B |
6.1% |
2024 |
| ADEAAdeia Inc. |
$443.4M |
25.1% |
2025 |
| ADIAAdia Nutrition, Inc. |
$700.5K |
-56.5% |
2025 |
| ACETAdicet Bio, Inc. |
n/a |
n/a |
2025 |
| ADNTAdient plc |
$14.5B |
-1.9% |
2025 |
| ADTXAditxt, Inc. |
$3.2K |
-1,349,028.2% |
2025 |
| ANLAdlai Nortye Ltd. |
n/a |
n/a |
2024 |
| ADSEAds-Tec Energy Public Ltd Co |
€110M |
-89.0% |
2024 |
| ASIXAdvanSix Inc. |
$1.5B |
3.2% |
2025 |
| ADVBAdvanced Biomed Inc. |
n/a |
n/a |
2025 |
| AFCGAdvanced Flower Capital Inc. |
$24.6M |
-85.7% |
2025 |
| ADVAdvantage Solutions Inc. |
$3.5B |
-6.4% |
2025 |